Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Denali Capital Acquisition Unit | DECAU | Oct 31, 2024 | 11.53 | 0.00 |
Denali Therapeutics | DNLI | Oct 31, 2024 | 25.96 | -3.31 |
Denison Mines | DNN | Oct 31, 2024 | 2.10 | -2.33 |
Dennys | DENN | Oct 31, 2024 | 6.41 | -3.17 |
DENTSPLY SIRONA | XRAY | Oct 31, 2024 | 23.17 | -1.03 |
Dermata Therapeutics | DRMA | Oct 31, 2024 | 1.27 | -5.93 |
Descartes Systems Group | DSGX | Oct 31, 2024 | 103.93 | -2.39 |
Design Therapeutics | DSGN | Oct 31, 2024 | 5.24 | -5.92 |
Designer Brands A | DBI | Oct 31, 2024 | 5.21 | -2.07 |
Desktop Metal A | DM | Oct 31, 2024 | 4.91 | +0.20 |
Despegar.com | DESP | Oct 31, 2024 | 14.44 | -0.41 |
Destiny Tech100 | DXYZ | Oct 31, 2024 | 10.79 | -5.02 |
Destra Multialternative Fund | DMA | Oct 31, 2024 | 8.69 | +0.35 |
Deswell Industries | DSWL | Oct 31, 2024 | 2.54 | -3.66 |
Deutsche Bank | DB | Oct 31, 2024 | 16.94 | +1.13 |
Dev Mkts Ex-US Alphadex First Trust | FDT | Oct 31, 2024 | 55.82 | -0.57 |
Dev Mkts Ex-US SC Alphadex First Trust | FDTS | Oct 31, 2024 | 41.67 | +0.36 |
Devon Energy | DVN | Oct 31, 2024 | 38.68 | +0.86 |
DexCom | DXCM | Oct 31, 2024 | 70.48 | -1.84 |
DHI Group | DHX | Oct 31, 2024 | 1.64 | -6.29 |
DHT | DHT | Oct 31, 2024 | 10.32 | +0.29 |
Diageo ADR | DEO | Oct 31, 2024 | 124.16 | -2.81 |
DiaMedica Therapeutics | DMAC | Oct 31, 2024 | 4.37 | +0.23 |
Diamond Hill Investment Group A | DHIL | Oct 31, 2024 | 150.92 | -2.66 |
Diamondback Energy | FANG | Oct 31, 2024 | 176.77 | +0.07 |
DiamondRock Hospitality | DRH | Oct 31, 2024 | 8.57 | -3.60 |
Diamondrock Hospitality A Pref | DRH-A | Oct 31, 2024 | 25.95 | 0.00 |
Diana Shipping | DSX | Oct 31, 2024 | 2.30 | +5.50 |
Diana Shipping B Pref | DSX-B | Oct 31, 2024 | 26.60 | +0.04 |
Dianthus Therapeutics | DNTH | Oct 31, 2024 | 27.86 | -0.36 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.